Ftse Mib
33.860,73
0,37%
DAX
17.978,40
0,41%
S&P 500
5.064,20
0,91%
NASDAQ
15.840,96
1,51%
Bitcoin
59.431,23
0,52%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Liminal BioSciences Inc (LMNL) Liminal BioSciences Inc (LMNL) Notizie

Liminal BioSciences Inc

LMNL
8,50
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 02:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/10/202314:30EDGAR2Form 15-12G - Securities registration termination [Section..
27/9/202322:05EDGAR2Form SC 13D/A - General statement of acquisition of..
27/9/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
26/9/202315:12EDGAR2Form POS AM - Post-Effective amendments for registration..
26/9/202315:08EDGAR2Form 25-NSE - Notification filed by national security..
26/9/202314:57EDGAR2Form S-8 POS - Securities to be offered to employees in..
26/9/202314:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/9/202314:54EDGAR2Form SC 13E3/A - Going private transaction by certain..
26/9/202314:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/9/202314:00PRNUSLIMINAL BIOSCIENCES ANNOUNCES COMPLETION OF THE PLAN OF..
19/9/202322:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/9/202322:34PRNUSLIMINAL BIOSCIENCES RECEIVES FINAL COURT ORDER FOR PLAN OF..
19/9/202322:22PRNCALIMINAL BIOSCIENCES RECEIVES FINAL COURT ORDER FOR PLAN OF..
15/9/202318:03PRNUSLIMINAL BIOSCIENCES SHAREHOLDERS APPROVE PLAN OF ARRANGEMENT..
15/9/202318:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/9/202317:29PRNUSLIMINAL BIOSCIENCES SHAREHOLDERS APPROVE PLAN OF ARRANGEMENT..
12/9/202314:38EDGAR2Form SC 13E3/A - Going private transaction by certain..
12/9/202314:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/9/202314:02PRNUSLIMINAL BIOSCIENCES FILES AMENDED SCHEDULE 13E-3 AND..
12/9/202313:45PRNCALIMINAL BIOSCIENCES FILES AMENDED SCHEDULE 13E-3 AND..
16/8/202323:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/8/202323:20PRNUSLIMINAL BIOSCIENCES OBTAINS INTERIM ORDER FOR PROPOSED..
16/8/202322:46PRNUSLIMINAL BIOSCIENCES OBTAINS INTERIM ORDER FOR PROPOSED..
08/8/202322:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/8/202322:05PRNUSLiminal BioSciences Reports Second Quarter Financial Results..
02/8/202322:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/7/202323:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/7/202313:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/7/202313:30PRNUSLiminal BioSciences Announces Arrangement Agreement with..
05/6/202322:05PRNCALiminal BioSciences Announces Voting Results of its 2023..
02/6/202314:00PRNCALiminal BioSciences Provides R&D Update
09/5/202322:05PRNCALiminal BioSciences Reports First Quarter Financial Results..
08/5/202314:00PRNCAThe Special Committee of the Board of Directors of Liminal..
Apertura: Min: Max:
Chiusura: 8,50

La tua Cronologia

NASDAQ
LMNL
Liminal BioSciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network